Natalie Jones

Natalie Jones earned a Bachelor’s degree in Chemistry at the University of Washington. She began her career in biotech at Amgen in 2013 and then later joined the emerging ADC leader Seattle Genetics. Currently she is a Senior Scientist within the Characterization and Analytical Sciences Department at Pfizer, located in Bothell, Washington. She has accumulated over a decade of specialized experience in the characterization and method development of Antibody Drug Conjugates (ADC). Her expertise has played a role in advancement of ADCs by developing robust and reliable analytical methods designed to ensure both the efficacy and safety of ADCs. More recently she has explored alternative analytical methodologies tailored for novel ADCs, especially those for which conventional techniques have proven insufficient. This work has focused on integrating creative scientific solutions with practical applications to drive forward the capabilities of ADC characterization and method development.